tiprankstipranks
Advertisement
Advertisement

COLL Stock Latest News

Collegium: Strategic AZSTARYS Acquisition Underpins ADHD Franchise Expansion and Supports Buy Rating
RatingsCollegium: Strategic AZSTARYS Acquisition Underpins ADHD Franchise Expansion and Supports Buy Rating
24d ago
COLL
Collegium Pharmaceutical to Acquire AZSTARYS ADHD Franchise
PremiumCompany Announcements
Collegium Pharmaceutical to Acquire AZSTARYS ADHD Franchise
24d ago
8K
COLL
Collegium Pharmaceutical to acquire AZSTARYS for $650M in cash
PremiumThe Fly
Collegium Pharmaceutical to acquire AZSTARYS for $650M in cash
25d ago
COLL
Collegium, Paris Hilton announce ‘Embrace Your Sparkle’ campaign
PremiumThe Fly
Collegium, Paris Hilton announce ‘Embrace Your Sparkle’ campaign
1M ago
COLL
Collegium Pharmaceutical Earnings Call: Jornay Leads Growth
PremiumCompany Announcements
Collegium Pharmaceutical Earnings Call: Jornay Leads Growth
2M ago
COLL
Collegium Reports Record 2025 Results and Reaffirms Outlook
PremiumCompany AnnouncementsCollegium Reports Record 2025 Results and Reaffirms Outlook
2M ago
8K
COLL
Collegium Pharmaceutical reports Q4 adjusted EPS $2.04, consensus $2.14
Premium
The Fly
Collegium Pharmaceutical reports Q4 adjusted EPS $2.04, consensus $2.14
2M ago
COLL
Collegium Pharmaceutical sees FY26 product revenue $805M-$825M
Premium
The Fly
Collegium Pharmaceutical sees FY26 product revenue $805M-$825M
2M ago
COLL
Collegium Pharmaceutical Inc. (COLL) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Collegium Pharmaceutical Inc. (COLL) Q4 Earnings Cheat Sheet
2M ago
COLL
Collegium Pharmaceutical enters multiyear partnership with Boston Legacy FC
PremiumThe Fly
Collegium Pharmaceutical enters multiyear partnership with Boston Legacy FC
2M ago
COLL
Collegium Pharmaceutical price target raised to $58 from $55 at Truist
PremiumThe Fly
Collegium Pharmaceutical price target raised to $58 from $55 at Truist
2M ago
COLL
Collegium Pharmaceutical management to meet with Truist
PremiumThe Fly
Collegium Pharmaceutical management to meet with Truist
2M ago
COLL
Collegium price target lowered to $56 from $58 at Barclays
PremiumThe FlyCollegium price target lowered to $56 from $58 at Barclays
3M ago
COLL
Collegium Pharmaceutical price target raised to $60 from $46 at H.C. Wainwright
Premium
The Fly
Collegium Pharmaceutical price target raised to $60 from $46 at H.C. Wainwright
3M ago
COLL
Collegium Pharmaceutical: Strengthened 2026 Outlook, Balance Sheet Flexibility, and BD Upside Support Buy Rating and Higher Target
Premium
Ratings
Collegium Pharmaceutical: Strengthened 2026 Outlook, Balance Sheet Flexibility, and BD Upside Support Buy Rating and Higher Target
3M ago
COLL
Collegium Issues 2026 Guidance Emphasizing Jornay PM Growth
PremiumCompany Announcements
Collegium Issues 2026 Guidance Emphasizing Jornay PM Growth
3M ago
8K
COLL
Collegium Pharmaceutical sees FY26 produce revenue $805M-$825M
PremiumThe Fly
Collegium Pharmaceutical sees FY26 produce revenue $805M-$825M
3M ago
COLL
Collegium Pharmaceutical price target raised to $55 from $47 at Truist
PremiumThe Fly
Collegium Pharmaceutical price target raised to $55 from $47 at Truist
3M ago
COLL
Collegium Pharmaceutical Closes New $980 Million Credit Facility
PremiumCompany Announcements
Collegium Pharmaceutical Closes New $980 Million Credit Facility
3M ago
8K
COLL
Collegium Pharmaceutical closes $980M syndicated credit facility
PremiumThe FlyCollegium Pharmaceutical closes $980M syndicated credit facility
3M ago
COLL
Dyne Therapeutics appoints Vikram Karnani to board of directors
Premium
The Fly
Dyne Therapeutics appoints Vikram Karnani to board of directors
4M ago
DYN
COLL
Collegium Pharmaceutical initiated with an Overweight at Barclays
Premium
The Fly
Collegium Pharmaceutical initiated with an Overweight at Barclays
4M ago
COLL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >